NCT00591175 is a clinical trial of Standard Care only in Smoking Cessation, sponsored by Memorial Sloan Kettering Cancer Center.

Who is sponsoring NCT00591175?

NCT00591175 is sponsored by Memorial Sloan Kettering Cancer Center.

What drugs are being tested in NCT00591175?

Interventions in NCT00591175: Standard Care only, Dental Hygienist provided counseling + Brief Questionnaire, Dental Hygienist provided counseling with personalized risk communication + Brief Questionnaire.

What condition does NCT00591175 study?

NCT00591175 studies Smoking Cessation.

Is NCT00591175 still recruiting?

NCT00591175 is currently active, enrolled. Last updated 5 January 2026.

Last reviewed 2026-01-05 · How we verify

NCT00591175

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers

Active, enrolled Last updated 5 January 2026

What this trial tests

trial testing Standard Care only in Smoking Cessation in 1,072 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 December 2001

Primary endpoint
1 December 2026

1 December 2026

Quick facts

Lead sponsor	Memorial Sloan Kettering Cancer Center
Status	Active, enrolled
Study type	OBSERVATIONAL
Enrollment	1,072
Start date	1 December 2001
Primary completion	1 December 2026
Estimated completion	1 December 2026
Sites	1 location across United States

Drugs / interventions tested

Standard Care only
Dental Hygienist provided counseling + Brief Questionnaire
Dental Hygienist provided counseling with personalized risk communication + Brief Questionnaire

Conditions studied

Smoking Cessation — all drugs for Smoking Cessation →

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

18 and older, any sex, with Smoking Cessation. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

efficacy of varied smoking cessation interventions
Time frame: 1 year

Sponsor's own description

The goal of this study is to see if giving patients information about how smoking affects oral health will help them quit smoking. What we learn from this study will help researchers find new ways to help smokers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for tobacco cessation delivered by dental professionals.
Holliday R, Hong B, McColl E, Livingstone-Banks J, et al · · 2021 · cited 46× · PMID 33605440 · DOI 10.1002/14651858.cd005084.pub4

Verify or expand the search:

Other recruiting trials for Smoking Cessation

Currently open trials in the same condition.

NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00591175 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 5 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00591175.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing